LINHAI TIANYU PHARMACEUTICAL CO LTD

Overview

LINHAI TIANYU PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 11 active FDA Type II Drug Master Files, covering APIXABAN; AZILSARTAN; AZILSARTAN KAMEDOXOMIL; DAPAGLIFLOZIN; FEBUXOSTAT; MONTELUKAST BACKONE DIOL.

API / Drug Master Files

LINHAI TIANYU PHARMACEUTICAL CO LTD holds 11 active (11 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• VALSARTAN DISODIUM (PROCESS III)Active2025-09-29
• VALSARTAN DISODIUM (PROCESS II)Active2025-09-29
• FEBUXOSTATActive2025-08-05
• AZILSARTAN KAMEDOXOMILActive2025-07-23
• DAPAGLIFLOZINActive2025-01-09
• AZILSARTANActive2024-03-25
• TICAGRELORActive2024-03-19
• VILDAGLIPTINActive2024-03-14
• APIXABANActive2024-03-04
• SACUBITRIL VALSARTAN SODIUM (INTERNAL CODE: LCZ696)Active2024-01-27
• MONTELUKAST BACKONE DIOLActive2014-09-30

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to LINHAI TIANYU PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.